MolNFT v1 · #175250 · protein
Cryo-EM structure of the human MCT1/BASIGIN-2 complex in the presence of anti-cancer drug candidate 7ACC2 in the inward-open conformation
7CKO: “Cryo-EM structure of the human MCT1/BASIGIN-2 complex in the presence of anti-cancer drug candidate 7ACC2 in…”. Electron microscopy, 1 ligand (G5L). MolNFT v1 #175250 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 7CKO
- Type
- protein
- Length
- 591 residues
- Chains
- 2
- Method
- electron microscopy
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- UniProt
- P53985, P35613
- Ligands
- G5L
Structure
electron microscopy · 2 distinct chains.
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | — | protein | 375 | — | P53985 |
| B | — | protein | 216 | — | P35613 |
Ligands and binding sites
- G5L · 7-[methyl-(phenylmethyl)amino]-2-oxidanylidene-chromene-3-carboxylic acid · ligand · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Compared structures
- 7CKO · Cryo-EM structure of the human MCT1/Basigin-2 complex in the presence of anti-cancer drug… · the same entry in another collection · chain A against A, TM-score 1.00
- P53985 · AlphaFold monomer V2.0 prediction for monocarboxylate transporter 1 (P53985) · a predicted model of the same protein · chain A against A, TM-score 0.98
- P35613 · AlphaFold monomer V2.0 prediction for basigin (P35613) · a predicted model of the same protein · chain B against A, TM-score 0.72
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P53985
- Every structure of UniProt P35613
- Elsewhere: RCSB PDB 7CKO · PDBe 7CKO · UniProt P53985 · UniProt P35613
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.